Chardan Capital Initiates Coverage On Vicore Pharma Holding with Buy Rating, Announces Price Target of $15

Benzinga · 2d ago
Chardan Capital analyst Andreas Argyrides initiates coverage on Vicore Pharma Holding (NASDAQ:VCRE) with a Buy rating and announces Price Target of $15.